by Adam | Jun 8, 2020 | News
PROVIDENCE, RI, June 8, 2020 /PRNewswire/ — EpiVax, Inc. (“EpiVax”) a Rhode Island-based company and recognized leader in the field in the field of immunogenicity assessment today announced it has licensed its advanced in silico toolkit for biologics...
by Annie De Groot | Nov 6, 2018 | Events
2nd International Conference on Therapeutic Antibodies in Mexico Thursday, November 29th and Friday, November 30th Hotel Hilton Reforma, CDMX We had a great time at this event! Check out photos from the seminar below. Annie De Groot – CEO/CSO, EpiVax Rob Etches...
